| Address:
|
1301 HARBOR BAY PARKWAY
. |
| City: |
ALAMEDA |
|
State: |
CA |
|
Zip Code: |
94502 |
| Telephone: |
510-748-7150 |
|
Description of Business
|
Primary SIC Code:
2835 |
| (As filed with the SEC)
|
|
|
Avigen is a biopharmaceutical company focused on developing and
commercializing small molecule therapeutics to treat serious neurological and
neuromuscular disorders. Our current lead product candidates primarily address
spasticity and neuromuscular spasm and neuropathic pain.
Our goal is to retain rights to commercialize our products in North America
and therefore we expect, when appropriate, to build a sales and marketing
infrastructure. We intend to seek to out-license rights to develop and market
our products outside the United States. We also intend to continue to look for
opportunities to expand our pipeline of compounds through a combination of
internal research, acquisitions, and in-licensing as appropriate. Avigen, Inc.
is a Delaware corporation that was incorporated on October 22, 1992 and is based
in the San Francisco Bay Area. ... More ... |
| Date |
12-mos
Rolling EPS |
Dividend |
P/E
Ratio |
| 03/2009 | -0.83 | NA | N/E | | 12/2008 | -0.84 | NA | N/E | | 09/2008 | -1.04 | NA | N/E | | 06/2008 | -0.96 | NA | N/E | | 03/2008 | -0.92 | NA | N/E | | 12/2007 | -0.90 | NA | N/E | | 09/2007 | -0.89 | NA | N/E | | 06/2007 | -0.88 | NA | N/E |
Key Financial Ratios and Statistics |
FYE:
12/31 |
| Profitability |
2008 |
Leverage |
2008 |
| Net Inc/Comm Equity | -0.09 | Total Liab/Total Assets | 0.19 | | Net Inc/Total Assets | -0.43 | Total Liab/Inv Cap | 0.27 | | Net Inc/Inv Cap | -0.62 | Total Liab/Comm Equity | 0.04 | | Pretax Inc/Net Sales | -3.54 | Interest Coverage Ratio | -84.66 | | Net Inc/Net Sales | -3.54 | Curr Debt/Equity | 0.15 | | Cash Flow/Net Sales | -2.98 | LTD/Equity | NA | | SG&A/NetSales | 1.22 | Total Debt/Equity | 0.15 |
| Asset Utilization
|
|
Liquidity |
|
| Net Receivables Turnover | 19.80 | Quick Ratio | 5.40 | | Inventory Turnover | NA | Current Ratio | 5.44 | | Inventory Day Sales | NA | Net Rec/Curr Assets | NA | | Net Sales/Work Cap | 0.16 | Inv/Curr Assets | 0.01 | | Net Sales/PP&E | 136.54 | | |
Income Statement (Millions) |
| |
3/31/2009
|
12/31/2008
|
9/30/2008
|
6/30/2008
|
|
Total Revenues(Net Sales)
|
NA
|
7.10
|
NA
|
NA
|
|
Cost of Goods Sold
|
NA
|
NA
|
NA
|
NA
|
|
Selling & Admin Exps
|
4.98
|
-0.20
|
4.35
|
2.26
|
|
Operating Income
|
-7.76
|
-1.38
|
-10.03
|
-8.16
|
|
Interest Exp
|
0.04
|
0.07
|
0.06
|
0.06
|
|
Pretax Income
|
-7.19
|
-0.94
|
-9.40
|
-7.34
|
|
Other Income
|
0.61
|
0.50
|
0.68
|
0.88
|
|
Net Income Bef Extraordinary ...
|
NA
|
NA
|
NA
|
NA
|
|
Net Income
|
-7.19
|
-0.94
|
-9.40
|
-7.34
|
|
Assets
|
3/31/2009
|
12/31/2008
|
9/30/2008
|
6/30/2008
|
|
Cash & Short Term Investments
|
42.50
|
54.84
|
47.41
|
56.31
|
|
Receivables - Total
|
0.40
|
NA
|
0.47
|
0.61
|
|
Inventories - Total
|
NA
|
0.47
|
NA
|
NA
|
|
Total Current Assets
|
43.16
|
55.75
|
48.33
|
57.59
|
|
Net Property, Plant & Equipment
|
0.04
|
0.05
|
0.53
|
0.62
|
|
Total Assets
|
45.43
|
58.05
|
58.11
|
67.36
|
|
Liabilities
|
|
|
|
|
|
Accounts Payable
|
4.42
|
3.12
|
3.26
|
3.15
|
|
Debt in Current Liabilities
|
NA
|
7.00
|
NA
|
NA
|
|
Total Current Liabilities
|
4.49
|
10.24
|
3.27
|
3.19
|
|
Long-Term Debt
|
NA
|
NA
|
7.00
|
7.00
|
|
Total Liabilities
|
5.08
|
10.84
|
10.92
|
10.82
|
|
Stockholder's Equity
|
|
|
|
|
|
Minority Interest
|
NA
|
NA
|
NA
|
NA
|
|
Preferred Stock
|
NA
|
NA
|
NA
|
NA
|
|
Common Stock
|
0.03
|
0.03
|
0.03
|
0.03
|
|
Retained Earnings
|
-252.99
|
-245.79
|
-244.85
|
-235.45
|
|
Treasury Stock
|
NA
|
NA
|
NA
|
NA
|
|
Total Stockholders' Equity
|
40.35
|
47.20
|
47.18
|
56.55
|
|
Total Liabilities and Stockholders' Equity
|
45.43
|
58.05
|
58.11
|
67.36
|
Cash Flow Summary (Millions) |
|
Categories
|
3/31/2009
|
12/31/2008
|
9/30/2008
|
6/30/2008
|
|
Net Cash Provided by Operating Activities
|
-5.17
|
0.03
|
-8.32
|
-6.17
|
|
Net Cash Provided by Investing Activities
|
3.92
|
1.36
|
13.57
|
7.16
|
|
Net Cash Provided by Financing Activities
|
-7.00
|
0.00
|
0.00
|
0.00
|
Annual Summary Data (Millions) |
| Year |
Sales |
Net
Income |
EPS |
| 12/2004 | 2.19 | -23.92 | -1.17 | | 12/2005 | 12.03 | -14.70 | -0.71 | | 12/2006 | 0.10 | -24.26 | -1.03 | | 12/2007 | 0.00 | -25.16 | -0.90 | | 12/2008 | 7.10 | -25.10 | -0.84 | | Growth Rates | 34.11 | -- | -- |
| Type |
Date(Q,M) |
No.
Owners |
Shares
Held (000s) |
%
Own |
| Institutional | 03/31/09 | 39 | 15,117 | 50.68 |
|
Report Date :
6/23/2009
 Copyright
2009, EDGAR Online, Inc. All
rights reserved. Replication or redistribution of EDGAR Online, Inc. content is
expressly prohibited without the prior written consent of EDGAR Online, Inc.
EDGAR Online, Inc. shall not be liable for any errors or delays in the content,
or for any actions taken in reliance thereon.
|
|
|